A critical role for the small GTPase Rho and one of its targets, p160ROCK (a Rho-associated coiled coil-forming protein kinase), in neurite remodeling was examined in neuroblastoma N1E-115 cells. Using wild-type and a dominant-negative form of p160ROCK and a p160ROCK-specific inhibitor, Y-27632, we show here that p160ROCK activation is necessary and sufficient for the agonist-induced neurite retraction and cell rounding. The neurite retraction was accompanied by elevated phosphorylation of myosin light chain and the disassembly of the intermediate filaments and microtubules. Y-27632 blocked both neurite retraction and the elevation of myosin light chain phosphorylation in a similar concentration-dependent manner. On the other hand, suppression of p160ROCK activity by expression of a dominant-negative form of p160ROCK induced neurites in the presence of serum by inducing the reassembly of the intermediate filaments and microtubules. The neurite outgrowth by the p160ROCK inhibition was blocked by coexpression of dominant-negative forms of Cdc42 and Rac, indicating that p160ROCK constitutively and negatively regulates neurite formation at least in part by inhibiting activation of Cdc42 and Rac. The assembly of microtubules and intermediate filaments to form extended processes by inhibitors of the Rho–ROCK pathway was also observed in Swiss 3T3 cells. These results indicate that Rho/ROCK-dependent tonic inhibition of cell process extension is exerted via activation of the actomysin-based contractility, in conjunction with a suppression of assembly of intermediate filaments and microtubules in many cell types including, but not exclusive to, neuronal cells.
Skip Nav Destination
Article navigation
29 June 1998
Article|
June 29 1998
Molecular Dissection of the Rho-associated Protein Kinase (p160ROCK)-regulated Neurite Remodeling in Neuroblastoma N1E-115 Cells
Masaya Hirose,
Masaya Hirose
*Department of Pharmacology, Kyoto University Faculty of Medicine, Sakyo, Kyoto 606-8315, Japan; ‡Discovery Research, Yoshitomi Pharmaceutical Industries, Iruma, Saitama 358-0026, Japan; §Division of Cellular Biochemistry, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands; and ‖Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, New Jersey 08855-1059
Search for other works by this author on:
Toshimasa Ishizaki,
Toshimasa Ishizaki
*Department of Pharmacology, Kyoto University Faculty of Medicine, Sakyo, Kyoto 606-8315, Japan; ‡Discovery Research, Yoshitomi Pharmaceutical Industries, Iruma, Saitama 358-0026, Japan; §Division of Cellular Biochemistry, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands; and ‖Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, New Jersey 08855-1059
Search for other works by this author on:
Naoki Watanabe,
Naoki Watanabe
*Department of Pharmacology, Kyoto University Faculty of Medicine, Sakyo, Kyoto 606-8315, Japan; ‡Discovery Research, Yoshitomi Pharmaceutical Industries, Iruma, Saitama 358-0026, Japan; §Division of Cellular Biochemistry, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands; and ‖Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, New Jersey 08855-1059
Search for other works by this author on:
Masayoshi Uehata,
Masayoshi Uehata
*Department of Pharmacology, Kyoto University Faculty of Medicine, Sakyo, Kyoto 606-8315, Japan; ‡Discovery Research, Yoshitomi Pharmaceutical Industries, Iruma, Saitama 358-0026, Japan; §Division of Cellular Biochemistry, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands; and ‖Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, New Jersey 08855-1059
Search for other works by this author on:
Onno Kranenburg,
Onno Kranenburg
*Department of Pharmacology, Kyoto University Faculty of Medicine, Sakyo, Kyoto 606-8315, Japan; ‡Discovery Research, Yoshitomi Pharmaceutical Industries, Iruma, Saitama 358-0026, Japan; §Division of Cellular Biochemistry, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands; and ‖Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, New Jersey 08855-1059
Search for other works by this author on:
Wouter H. Moolenaar,
Wouter H. Moolenaar
*Department of Pharmacology, Kyoto University Faculty of Medicine, Sakyo, Kyoto 606-8315, Japan; ‡Discovery Research, Yoshitomi Pharmaceutical Industries, Iruma, Saitama 358-0026, Japan; §Division of Cellular Biochemistry, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands; and ‖Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, New Jersey 08855-1059
Search for other works by this author on:
Fumio Matsumura,
Fumio Matsumura
*Department of Pharmacology, Kyoto University Faculty of Medicine, Sakyo, Kyoto 606-8315, Japan; ‡Discovery Research, Yoshitomi Pharmaceutical Industries, Iruma, Saitama 358-0026, Japan; §Division of Cellular Biochemistry, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands; and ‖Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, New Jersey 08855-1059
Search for other works by this author on:
Midori Maekawa,
Midori Maekawa
*Department of Pharmacology, Kyoto University Faculty of Medicine, Sakyo, Kyoto 606-8315, Japan; ‡Discovery Research, Yoshitomi Pharmaceutical Industries, Iruma, Saitama 358-0026, Japan; §Division of Cellular Biochemistry, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands; and ‖Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, New Jersey 08855-1059
Search for other works by this author on:
Haruhiko Bito,
Haruhiko Bito
*Department of Pharmacology, Kyoto University Faculty of Medicine, Sakyo, Kyoto 606-8315, Japan; ‡Discovery Research, Yoshitomi Pharmaceutical Industries, Iruma, Saitama 358-0026, Japan; §Division of Cellular Biochemistry, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands; and ‖Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, New Jersey 08855-1059
Search for other works by this author on:
Shuh Narumiya
Shuh Narumiya
*Department of Pharmacology, Kyoto University Faculty of Medicine, Sakyo, Kyoto 606-8315, Japan; ‡Discovery Research, Yoshitomi Pharmaceutical Industries, Iruma, Saitama 358-0026, Japan; §Division of Cellular Biochemistry, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands; and ‖Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, New Jersey 08855-1059
Search for other works by this author on:
Masaya Hirose
*Department of Pharmacology, Kyoto University Faculty of Medicine, Sakyo, Kyoto 606-8315, Japan; ‡Discovery Research, Yoshitomi Pharmaceutical Industries, Iruma, Saitama 358-0026, Japan; §Division of Cellular Biochemistry, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands; and ‖Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, New Jersey 08855-1059
Toshimasa Ishizaki
*Department of Pharmacology, Kyoto University Faculty of Medicine, Sakyo, Kyoto 606-8315, Japan; ‡Discovery Research, Yoshitomi Pharmaceutical Industries, Iruma, Saitama 358-0026, Japan; §Division of Cellular Biochemistry, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands; and ‖Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, New Jersey 08855-1059
Naoki Watanabe
*Department of Pharmacology, Kyoto University Faculty of Medicine, Sakyo, Kyoto 606-8315, Japan; ‡Discovery Research, Yoshitomi Pharmaceutical Industries, Iruma, Saitama 358-0026, Japan; §Division of Cellular Biochemistry, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands; and ‖Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, New Jersey 08855-1059
Masayoshi Uehata
*Department of Pharmacology, Kyoto University Faculty of Medicine, Sakyo, Kyoto 606-8315, Japan; ‡Discovery Research, Yoshitomi Pharmaceutical Industries, Iruma, Saitama 358-0026, Japan; §Division of Cellular Biochemistry, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands; and ‖Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, New Jersey 08855-1059
Onno Kranenburg
*Department of Pharmacology, Kyoto University Faculty of Medicine, Sakyo, Kyoto 606-8315, Japan; ‡Discovery Research, Yoshitomi Pharmaceutical Industries, Iruma, Saitama 358-0026, Japan; §Division of Cellular Biochemistry, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands; and ‖Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, New Jersey 08855-1059
Wouter H. Moolenaar
*Department of Pharmacology, Kyoto University Faculty of Medicine, Sakyo, Kyoto 606-8315, Japan; ‡Discovery Research, Yoshitomi Pharmaceutical Industries, Iruma, Saitama 358-0026, Japan; §Division of Cellular Biochemistry, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands; and ‖Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, New Jersey 08855-1059
Fumio Matsumura
*Department of Pharmacology, Kyoto University Faculty of Medicine, Sakyo, Kyoto 606-8315, Japan; ‡Discovery Research, Yoshitomi Pharmaceutical Industries, Iruma, Saitama 358-0026, Japan; §Division of Cellular Biochemistry, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands; and ‖Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, New Jersey 08855-1059
Midori Maekawa
*Department of Pharmacology, Kyoto University Faculty of Medicine, Sakyo, Kyoto 606-8315, Japan; ‡Discovery Research, Yoshitomi Pharmaceutical Industries, Iruma, Saitama 358-0026, Japan; §Division of Cellular Biochemistry, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands; and ‖Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, New Jersey 08855-1059
Haruhiko Bito
*Department of Pharmacology, Kyoto University Faculty of Medicine, Sakyo, Kyoto 606-8315, Japan; ‡Discovery Research, Yoshitomi Pharmaceutical Industries, Iruma, Saitama 358-0026, Japan; §Division of Cellular Biochemistry, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands; and ‖Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, New Jersey 08855-1059
Shuh Narumiya
*Department of Pharmacology, Kyoto University Faculty of Medicine, Sakyo, Kyoto 606-8315, Japan; ‡Discovery Research, Yoshitomi Pharmaceutical Industries, Iruma, Saitama 358-0026, Japan; §Division of Cellular Biochemistry, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands; and ‖Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, New Jersey 08855-1059
Address all correspondence to Shuh Narumiya, Department of Pharmacology, Kyoto University Faculty of Medicine, Sakyo, Kyoto 606-8315, Japan. Tel.: (81) 75-753-4392. Fax: (81) 75-753-4693. E-mail: [email protected]
M. Hirose and T. Ishizaki contributed equally to this work.
Received:
February 25 1998
Revision Received:
May 14 1998
Online ISSN: 1540-8140
Print ISSN: 0021-9525
1998
J Cell Biol (1998) 141 (7): 1625–1636.
Article history
Received:
February 25 1998
Revision Received:
May 14 1998
Citation
Masaya Hirose, Toshimasa Ishizaki, Naoki Watanabe, Masayoshi Uehata, Onno Kranenburg, Wouter H. Moolenaar, Fumio Matsumura, Midori Maekawa, Haruhiko Bito, Shuh Narumiya; Molecular Dissection of the Rho-associated Protein Kinase (p160ROCK)-regulated Neurite Remodeling in Neuroblastoma N1E-115 Cells . J Cell Biol 29 June 1998; 141 (7): 1625–1636. doi: https://doi.org/10.1083/jcb.141.7.1625
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement
Advertisement